Bifidobacterium genus bacterium
AssigneeMorinaga Milk Industry Co., Ltd.
InventorsTakuma Sakurai, Nanami Hashikura, Kanetada Shimizu, Sachiko Takahashi, Ayako Horigome
Life of this patent
Estimating the term…
Loading patent…
AssigneeMorinaga Milk Industry Co., Ltd.
InventorsTakuma Sakurai, Nanami Hashikura, Kanetada Shimizu, Sachiko Takahashi, Ayako Horigome
Estimating the term…
Novel Bifidobacterium bacteria having an opioid peptide decomposition action and a noncollagenous glycoprotein decomposition action are provided. The present invention relates to one or more kinds of Bifidobacterium bacteria selected from the group consisting of Bifidobacterium bifidum MCC1092 (NITE BP-02429), Bifidobacterium bifidum MCC1319 (NITE BP-02431), Bifidobacterium bifidum MCC1868 (NITE BP-02432), Bifidobacterium bifidum MCC1870 (NITE BP-02433), and Bifidobacterium longum subsp. longum MCC1110 (NITE BP-02430), as well as a composition for decomposing an opioid peptide and composition for decomposing a noncollagenous glycoprotein containing the Bifidobacterium bacteria as an active ingredient.
A cell powder comprising Bifidobacterium bacteria that has been dried, wherein the Bifidobacterium bacterium is Bifidobacterium bifidum MCC1319 deposited with the National Institute of Technology and Evaluation under the accession number NITE BP-02431.
Dependencies are inferred from the claim text.